{"filing":{"accession_number":"0001522767-26-000188","cik":"0001522767","ticker":"MRMD","company_name":"MARIMED INC.","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-23","primary_document":"mrmd-20260923.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276726000188/mrmd-20260923.htm"},"events":[{"id":34577,"run_id":31822,"accession_number":"0001522767-26-000188","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"MariMed announced the filing of a definitive proxy statement seeking stockholder approval of a proposed reverse stock split (1-for-50 to 1-for-100 ratio) at a special meeting scheduled for October 28, 2026. The reverse split is intended to position the company for potential listing on a U.S. national securities exchange. This is a governance event involving a shareholder vote on a capital structure amendment, distinct from the shareholder_vote_results category (which applies after voting occurs) and best classified as governance_other since it announces the proxy filing and solicitation rather than vote results.","company_name":"MARIMED INC.","ticker":"MRMD","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38335,"accession_number":"0001522767-26-000188","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"MariMed announced the filing of a definitive proxy statement seeking stockholder approval of a proposed reverse stock split (1-for-50 to 1-for-100 ratio) at a special meeting scheduled for October 28, 2026. The reverse split is intended to position the company for potential listing on a U.S. national securities exchange. This is a governance event involving a shareholder vote on a capital structure amendment, distinct from the shareholder_vote_results category (which applies after voting occurs) and best classified as governance_other since it announces the proxy filing and solicitation rather than vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:09:30.120623+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38335,"accession_number":"0001522767-26-000188","item_number":"8.01","item_title":"Other Events.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"MariMed announced the filing of a definitive proxy statement seeking stockholder approval of a proposed reverse stock split (1-for-50 to 1-for-100 ratio) at a special meeting scheduled for October 28, 2026. The reverse split is intended to position the company for potential listing on a U.S. national securities exchange. This is a governance event involving a shareholder vote on a capital structure amendment, distinct from the shareholder_vote_results category (which applies after voting occurs) and best classified as governance_other since it announces the proxy filing and solicitation rather than vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T20:09:30.120623+00:00","company_name":"MARIMED INC.","ticker":"MRMD","filing_date":"2026-09-23"}]}